Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2026

Feb 18, 2026

34129_dirs_2026-02-17_0190861b-40d4-4291-8d5f-4754861fa12b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2026-02-15

Reporting Person: Koenig Scott (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-15 Common Stock M 21165 Acquired 867240 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-15 Restricted Stock Unit $0 M 21165 Disposed Common Stock (21165) Direct

Footnotes

F1: On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.